T1	Intervention 35 132	oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy
T2	Intervention 531 678	randomized, double-blind placebo-controlled trial of oral clodronate in patients with bone metastases from tumors poorly responsive to chemotherapy
T3	Intervention 1005 1124	Patients were randomized to receive either clodronate 1,600 mg/day for one year or identical placebo-containing tablets
T4	Intervention 1126 1292	Various parameters such as Karnofsky performance status, pain score (measured by a visual-analogue scale) and analgesic requirement were recorded at monthly intervals
T5	Intervention 2549 2564	oral clodronate
